Medical News

RSS

TransEnterix selects SYSPRO ERP software

SYSPRO, the leading provider of visionary, pragmatic ERP software, has today announced that TransEnterix, a fast-growing medical device manufacturer based in Durham, North Carolina, has selected SYSPRO ERP software after a lengthy selection process that included a thorough analysis of seven mid-range ERP software providers.

11 Jun 2010

Sundise to implement Medidata Rave as its EDC and CDM solution

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that Traditional Chinese Medicine company Sundise will implement Medidata Rave as its electronic data capture and clinical data management solution. Selected for its ability to offer a broad global reach with local in-country support, Medidata will work with Sundise to conduct its first U.S. trial for its TCM treatment for liver fibrosis and will play a key role in supporting the company's strategy to launch in the U.S.

11 Jun 2010

Takeda receives pricing approval for NESINA in Japan

Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited has received pricing approval for NESINA® (alogliptin) in Japan. NESINA, a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, received regulatory approval from the Japanese Ministry of Health, Labour and Welfare on April 16, 2010. Furiex collaborated with Takeda to develop this product.

11 Jun 2010

Trevena's scientists present research data on GPCR biased ligands at two scientific conferences

Trevena Inc., a leader in the discovery of G-protein coupled receptor biased ligands, today announced that its scientists are presenting research data at two scientific conferences. These oral presentations highlight Trevena's research demonstrating that ligand bias at the angiotensin II type I receptor translates into differentiable and beneficial cardiovascular pharmacology in vivo.

11 Jun 2010

NeoPharm first-quarter net loss decreases to $1.4 million

NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its first quarter 2010 financial results.

11 Jun 2010

Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA

Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver® PTX® Drug-Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA), Zilver PTX is a self-expanding, highly durable nitinol stent that uses a proprietary, polymer-free technology to deliver a locally therapeutic dose of paclitaxel, an antiproliferative drug, to the target lesion.

11 Jun 2010

Overview of research into pathogenesis and clinical treatment of dry eye

Dry eye is one of the most common disorders encountered in ophthalmological practice. Its symptoms cause considerable discomfort and substantially reduce the patient's quality of life. As it is a complex and multifactorial condition, research investigating dry eye is a matter of great interest all over the world.

11 Jun 2010

Arcadia fourth-quarter net loss decreases to $19.4 million

Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare brand, today announced fourth quarter revenues of $25.5 million and a net loss of $19.2 million, or $0.11 per share, which compares to revenue of $25.9 million and a net loss of $36.7 million, or $0.27 per share for the same period in the fiscal 2009.

11 Jun 2010

Uncork the Cure to contribute funds for children's brain tumor research

Uncork the Cure – a festival involving wine, food and music – will contribute funds for research into the causes of and cure for children's gliomas or brain tumors.

11 Jun 2010

Zargis Medical signs exclusive license agreement with Boston-based Stethographics

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that it has entered into an agreement with Boston-based Stethographics, Inc. providing an exclusive license to patented, FDA-cleared Stethographics lung sounds analysis technology that automatically identifies clinically significant respiratory sounds.

11 Jun 2010

Otonomy completes $10 million Series A financing with Avalon Ventures

Otonomy, Inc. announced today that it has completed a $10 million Series A financing with Avalon Ventures. Proceeds from the financing will be used to support the ongoing clinical trial for OTO-104 in Meniere's disease, initiate IND-enabling studies for OTO-203, and continue early-stage development of a third program.

11 Jun 2010

Series of regional meetings focused on ACOs are drawing healthcare leaders together: AMGA

The American Medical Group Association announced that the most recent in a series of regional meetings focused on accountable care organizations, hosted by Group Health Permanente in Seattle, Washington, continued to build on the success of previous meetings in the series. The meetings are drawing healthcare leaders together to network in an intimate setting and to learn from leading medical groups and organized systems of care that are exemplars of the ACO model.

11 Jun 2010

$125M added to plaintiffs' compensation in WTC site operations

The WTC Captive Insurance Company, the City of New York, the contractors the City hired, their subcontractors, and attorneys for over 10,000 plaintiffs alleging injuries from the rescue, recovery and debris removal operations at the World Trade Center site operations after 9/11 today announced amendments to a March 11, 2010 settlement of those claims.

11 Jun 2010

Interactions between human and microbial cells determine health, physical well-being: Researchers

At birth, your body was 100-percent human in terms of cells. At death, about 10-percent of the cells in your body will be human and the remaining 90-percent will be microorganisms. That makes you a "supraorganism," and it is the interactions between your human and microbial cells that go a long way towards determining your health and physical well-being, especially your resistance to infectious diseases.

11 Jun 2010

Study results of genes regulated by ERB published in Journal of Biological Chemistry

Bionovo Inc. today announced the publication of results from a study demonstrating the three distinct classes of genes regulated by estrogen receptor beta. The results are published in the Journal of Biological Chemistry. This is an important discovery for future development of selective drugs regulating this pathway.

11 Jun 2010

Seminar on pros and cons of robotic surgery

Robotic surgery - is it truly an advance for modern medicine, or just a product of slick consumer advertising campaigns and targeted marketing to physicians?

11 Jun 2010

Study on health disparities and sexual orientation

A recent study conducted by Northeastern University's Institute on Urban Health Research found a significant number of health disparities in Massachusetts between heterosexual adults and gay, lesbian and bisexual adults.

11 Jun 2010

BMS employees across Canada taking part in third annual Community Action Day

More than 300 employees of Bristol-Myers Squibb Canada will get the day off from their regular work today, but they won't be taking it easy. Instead, they will be joining company retirees and members of their own families in helping out at a variety of community and charitable organizations as part of the company's third annual BMS Community Action Day.

11 Jun 2010

Dabigatran Etexilate anticoagulant as effective as Enoxaparin in preventing venous thromboembolism

Data from the RE-NOVATE® II study presented today at the 15th Annual Congress of the European Hematology Association (EHA) have shown that dabigatran etexilate 220mg once daily is as effective and safe as enoxaparin 40mg in preventing venous thromboembolism (VTE) after total hip replacement surgery.

11 Jun 2010

New study to use genetic 'chips' for examining DNA from over 20,000 heart disease patients

New research at the University of Leicester will use the latest genetic techniques to examine DNA from over 20,000 patients with heart disease.

11 Jun 2010

Medical News

TransEnterix selects SYSPRO ERP software

Sundise to implement Medidata Rave as its EDC and CDM solution

Takeda receives pricing approval for NESINA in Japan

Trevena's scientists present research data on GPCR biased ligands at two scientific conferences

NeoPharm first-quarter net loss decreases to $1.4 million

Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA

Overview of research into pathogenesis and clinical treatment of dry eye

Arcadia fourth-quarter net loss decreases to $19.4 million

Uncork the Cure to contribute funds for children's brain tumor research

Zargis Medical signs exclusive license agreement with Boston-based Stethographics

Otonomy completes $10 million Series A financing with Avalon Ventures

Series of regional meetings focused on ACOs are drawing healthcare leaders together: AMGA

$125M added to plaintiffs' compensation in WTC site operations

Interactions between human and microbial cells determine health, physical well-being: Researchers

Study results of genes regulated by ERB published in Journal of Biological Chemistry

Seminar on pros and cons of robotic surgery

Study on health disparities and sexual orientation

BMS employees across Canada taking part in third annual Community Action Day

Dabigatran Etexilate anticoagulant as effective as Enoxaparin in preventing venous thromboembolism

New study to use genetic 'chips' for examining DNA from over 20,000 heart disease patients

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News